Unknown

Dataset Information

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.


ABSTRACT:

Background

In the United States, hepatitis C virus (HCV) infection is most prevalent among adults born from 1945 through 1965, and approximately 50% to 75% of infected adults are unaware of their infection.

Objective

To estimate the cost-effectiveness of birth-cohort screening.

Design

Cost-effectiveness simulation.

Data sources

National Health and Nutrition Examination Survey, U.S. Census, Medicare reimbursement schedule, and published sources.

Target population

Adults born from 1945 through 1965 with 1 or more visits to a primary care provider annually.

Time horizon

Lifetime.

Perspective

Societal, health care.

Intervention

One-time antibody test of 1945-1965 birth cohort.

Outcome measures

Numbers of cases that were identified

SUBMITTER: Rein DB 

PROVIDER: S-EPMC5484577 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature